| 1 |
Salvatore T, Galiero R, Caturano A, Rinaldi L, Criscuolo L, Di Martino A, Albanese G, Vetrano E, Catalini C, Sardu C, Docimo G, Marfella R, Sasso FC. Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes. Int J Mol Sci 2022;24. [PMID: 36614099 DOI: 10.3390/ijms24010658] [Reference Citation Analysis]
|
| 2 |
Shrestha S, Erikson G, Lyon J, Spigelman AF, Bautista A, Manning Fox JE, Dos Santos C, Shokhirev M, Cartailler JP, Hetzer MW, MacDonald PE, Arrojo E Drigo R. Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. Sci Adv 2022;8:eabo3932. [PMID: 36197983 DOI: 10.1126/sciadv.abo3932] [Reference Citation Analysis]
|
| 3 |
Vipin VA, Blesson CS, Yallampalli C. Maternal low protein diet and fetal programming of lean type 2 diabetes. World J Diabetes 2022; 13(3): 185-202 [DOI: 10.4239/wjd.v13.i3.185] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Sasaki H, Saisho Y, Itoh H. DPP-4 inhibitors and beta cell mass in Japanese adults with type 2 diabetes. Endocr Pract 2022:S1530-891X(22)00042-8. [PMID: 35143998 DOI: 10.1016/j.eprac.2022.02.001] [Reference Citation Analysis]
|
| 5 |
Sasaki H, Saisho Y, Inaishi J, Itoh H. Revisiting Regulators of Human β-cell Mass to Achieve β-cell-centric Approach Toward Type 2 Diabetes. J Endocr Soc 2021;5:bvab128. [PMID: 34405128 DOI: 10.1210/jendso/bvab128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
O'Hara SE, Gembus KM, Nicholas LM. Understanding the Long-Lasting Effects of Fetal Nutrient Restriction versus Exposure to an Obesogenic Diet on Islet-Cell Mass and Function. Metabolites 2021;11:514. [PMID: 34436455 DOI: 10.3390/metabo11080514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Sasaki H, Saisho Y, Inaishi J, Watanabe Y, Tsuchiya T, Makio M, Sato M, Nishikawa M, Kitago M, Yamada T, Itoh H. Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes. Diabetologia 2021;64:1816-21. [PMID: 33938968 DOI: 10.1007/s00125-021-05467-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Inaishi J, Saisho Y. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review. Nutrients 2020;12:E3846. [PMID: 33339276 DOI: 10.3390/nu12123846] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 9 |
Saisho Y. An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective. Expert Opin Pharmacother 2020;21:1565-78. [PMID: 32521177 DOI: 10.1080/14656566.2020.1776262] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
